MDT

84

-0.14%↓

VEEV

225.63

-0.54%↓

A

106.87

+0.63%↑

WBA

10.96

-0.36%↓

CHE

562.2

+1.12%↑

MDT

84

-0.14%↓

VEEV

225.63

-0.54%↓

A

106.87

+0.63%↑

WBA

10.96

-0.36%↓

CHE

562.2

+1.12%↑

MDT

84

-0.14%↓

VEEV

225.63

-0.54%↓

A

106.87

+0.63%↑

WBA

10.96

-0.36%↓

CHE

562.2

+1.12%↑

MDT

84

-0.14%↓

VEEV

225.63

-0.54%↓

A

106.87

+0.63%↑

WBA

10.96

-0.36%↓

CHE

562.2

+1.12%↑

MDT

84

-0.14%↓

VEEV

225.63

-0.54%↓

A

106.87

+0.63%↑

WBA

10.96

-0.36%↓

CHE

562.2

+1.12%↑

Search

Celldex Therapeutics Inc

Cerrado

SectorSalud

21.32 9.17

Resumen

Variación precio

24h

Actual

Mínimo

19.53

Máximo

21.39

Métricas clave

By Trading Economics

Ingresos

-5M

-47M

Ventas

-2M

1.2M

BPA

-0.71

Margen de beneficio

-4,007.83

Empleados

186

EBITDA

-3.9M

-55M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+202.15% upside

Dividendos

By Dow Jones

Próximas Ganancias

2 may 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-158M

1.3B

Apertura anterior

12.15

Cierre anterior

21.32

Puntuación técnica

By Trading Central

Confianza

Very Strong Bullish Evidence

Celldex Therapeutics Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

28 abr 2025, 23:27 UTC

Principales Noticias

Woodside Energy Approves $17.5 Billion Louisiana LNG Development -- 2nd Update

28 abr 2025, 23:07 UTC

Principales Noticias

Woodside Energy Approves $17.5 Billion Louisiana LNG Development -- Update

28 abr 2025, 23:03 UTC

Ganancias

Waste Management 1Q Profit Falls, Revenue Misses Estimates

28 abr 2025, 23:47 UTC

Charlas de Mercado

Gold Edges Lower as Traders Assess Mixed Signals From Treasury Secretary Bessent -- Market Talk

28 abr 2025, 23:17 UTC

Ganancias

Jiangxi Copper 1Q Rev CNY111.61B Vs. CNY122.52B >0358.HK

28 abr 2025, 23:17 UTC

Ganancias

Jiangxi Copper 1Q Net CNY1.95B Vs. Net CNY1.71B >0358.HK

28 abr 2025, 23:13 UTC

Ganancias

China Merchants Securities: Higher Interest Income, Fee Income Also Aided 1Q Results>600999.SH

28 abr 2025, 23:13 UTC

Ganancias

China Merchants Securities 1Q Rev CNY4.71B Vs. CNY4.30B >600999.SH

28 abr 2025, 23:13 UTC

Ganancias

China Merchants Securities: Gains From Investments in Financial Instruments Supported Results >600999.SH

28 abr 2025, 23:13 UTC

Ganancias

China Merchants Securities 1Q Net CNY2.31B Vs. Net CNY2.16B >600999.SH

28 abr 2025, 23:08 UTC

Ganancias

China Longyuan Power: 1Q Power Generation Declined 4.42% on Year>0916.HK

28 abr 2025, 23:08 UTC

Ganancias

China Longyuan Power 1H Rev CNY8.14B Vs. CNY8.07B >0916.HK

28 abr 2025, 23:08 UTC

Ganancias

China Longyuan Power 1H Net CNY1.98B Vs. Net CNY2.53B >0916.HK

28 abr 2025, 23:04 UTC

Ganancias

Huaneng Power: 1Q Net Was Mainly Driven By Decline in Domestic Fuel Costs >0902.HK

28 abr 2025, 23:04 UTC

Ganancias

Huaneng Power: Decrease in Electricity Tariffs Weighed on Rev >0902.HK

28 abr 2025, 23:04 UTC

Ganancias

Huaneng Power 1Q Rev CNY60.33B ; Down 7.7% on Year>0902.HK

28 abr 2025, 23:04 UTC

Ganancias

Huaneng Power 1Q Net CNY4.97B; up 8.2% on Year >0902.HK

28 abr 2025, 23:00 UTC

Ganancias

Jiangsu Expressway 1Q Rev CNY4.78B Vs. CNY3.47B >0177.HK

28 abr 2025, 23:00 UTC

Ganancias

Jiangsu Expressway: 1Q Rev Rose Due to Increase in Road Construction Projects >0177.HK

28 abr 2025, 23:00 UTC

Ganancias

Jiangsu Expressway: Decline in Investment Income, Fall in Revenue Post Asset Disposal Weighed on 1Q Net >0177.HK

28 abr 2025, 23:00 UTC

Ganancias

Jiangsu Expressway 1Q Net CNY1.21B Vs. Net CNY1.25B >0177.HK

28 abr 2025, 22:57 UTC

Principales Noticias

Trump Signs Order Requiring Nationwide List of Sanctuary Cities and States -- 8th Update

28 abr 2025, 22:55 UTC

Ganancias

Tsingtao Brewery: Higher Sales Volumes of Beer Supported Results >0168.HK

28 abr 2025, 22:55 UTC

Ganancias

Tsingtao Brewery 1Q Net CNY1.71B Vs. Net CNY1.60B >0168.HK

28 abr 2025, 22:55 UTC

Ganancias

Tsingtao Brewery 1Q Rev CNY10.45B Vs. CNY10.15B >0168.HK

28 abr 2025, 22:52 UTC

Ganancias

S.F. Holding: Results Supported by Higher Contributions From Logistics Business >002352.SZ

28 abr 2025, 22:52 UTC

Ganancias

S.F. Holding 1Q Net CNY2.23B Vs. Net CNY1.91B >002352.SZ

28 abr 2025, 22:52 UTC

Ganancias

S.F. Holding: Cost Controls Also aided 1Q Results >002352.SZ

28 abr 2025, 22:52 UTC

Ganancias

S.F. Holding 1Q Rev CNY69.85B Vs. CNY65.34B >002352.SZ

28 abr 2025, 22:46 UTC

Ganancias

Shandong Gold Mining: Increase in Selling Price of Gold Supported Results>600547.SH

Comparación entre iguales

Cambio de precio

Celldex Therapeutics Inc Esperado

Precio Objetivo

By TipRanks

202.15% repunte

Estimación a 12 meses

Media 59.13 USD  202.15%

Máximo 80 USD

Mínimo 36 USD

De acuerdo con 9 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Celldex Therapeutics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

9 ratings

8

Comprar

1

Mantener

0

Vender

Puntuación técnica

By Trading Central

19.39 / 19.58Soporte y Resistencia

Corto Plazo

Very Strong Bullish Evidence

Medio plazo

Neutral Evidence

Largo Plazo

Bearish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Celldex Therapeutics Inc

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.